UK quantum strategy highlights opportunity for specialist magnet systems

Avingtrans plc

The UK has unveiled a new strategy to scale its quantum computing sector, backed by up to £2 billion of investment. The aim is to make the UK the first country to roll out quantum computers at scale, with large-scale systems designed, built and deployed domestically by the early 2030s.

Quantum computing is moving from a research-led market towards a more structured commercial opportunity.

Scientific Magnetics designs and manufactures superconducting magnets for quantum computing qubit architecture. These systems are a critical part of the physical infrastructure required by some quantum technologies, where stable and precise magnetic environments are needed to support performance.

The UK strategy is important because it gives the sector a clearer route to scale. It is not only focused on scientific progress. It also covers deployment, domestic capability, skills, procurement and infrastructure. Quantum computers will need more than promising research to become commercially useful. They will need dependable systems, reliable components and a supply chain capable of supporting larger deployments.

As quantum computing moves closer to real-world use, investors are likely to pay closer attention to companies that can provide enabling technologies. Superconducting magnets sit within that category. They may not be the most visible part of quantum computing, but they are part of the engineering base that supports system performance.

Scientific Magnetics’ focus on superconducting magnet systems gives it exposure to a specialist part of the quantum hardware market, where technical expertise and reliability are likely to be important.

Avingtrans plc (LON:AVG) has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”. 

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Avingtrans plc: Record £163m Revenue, 90% Order Cover and Adaptix Nears Commercial Breakthrough

Avingtrans CEO Steve McQuillan discusses record £163m revenue, more than 90% order coverage and growing nuclear opportunities, while Adaptix moves from regulatory approvals towards commercial orthopaedic sales.

Avingtrans reports record revenue and strong profit growth as AI and nuclear demand builds

Avingtrans reported record revenue of £163.3m for FY2026, with adjusted EBITDA rising 24% to £20.7m as strong demand across AI infrastructure, data centres, electrification and nuclear power supported growth.

Avingtrans acquires US nuclear specialist Joseph Oat for $2.5m

Avingtrans has acquired the intellectual property, trading history and brand of US nuclear engineering specialist Joseph Oat for $2.5m, expanding its nuclear capabilities and access to legacy equipment across the US power sector.

Adaptix expands US distribution with Digital X-Ray Technologies partnership

Adaptix has appointed Digital X-Ray Technologies as a US distributor for the Ortho350, expanding access to its 3D orthopaedic imaging system across the West Coast and Pacific Islands.

Booth Industries strengthens infrastructure credentials with completed Silvertown Tunnel project

Booth Industries completed a circa £1.3 million Silvertown Tunnel contract in 2024, supplying and installing 25 specialist fire and pressure-resistant doorsets.

Adaptix secures US Federal sales channel for Ortho350

Adaptix has secured a dedicated US federal sales channel for the Ortho350 through an exclusive reseller agreement with Spartan Medical.

Search